Why Stopping Semaglutide Often Leads to Weight Regain—and How to Fight It

Semaglutide, a medication used for weight loss and diabetes management, often leads to regained weight once patients stop taking it. Studies show that, on average, people recover around 60% of their lost weight within a year of discontinuation. However, lifestyle changes—such as diet and exercise—may help slow this process.

Semaglutide works by balancing blood sugar, reducing appetite, and increasing feelings of fullness. It is the key ingredient in Wegovy, Ozempic, and Rybelsus. Among these, only Wegovy holds FDA approval for weight loss and lowering cardiovascular disease risk, while the others are officially approved for type 2 diabetes.

In clinical trials, adults took semaglutide for up to a year, with follow-ups extending beyond. After stopping the drug, participants regained weight at an average rate of 0.4 kg per month. Despite this, some managed to keep a portion of their weight off through diet and exercise.

Healthcare providers sometimes prescribe Ozempic or Rybelsus off-label for weight management. However, semaglutide is designed for long-term use, and restarting it later does not ensure lasting results. Experts suggest that working with a professional team—such as dietitians and fitness trainers—can improve long-term weight control.

To help maintain weight loss, patients are advised to include more protein and produce in meals, replicating the fullness effect of the medication. Regular physical activity also plays a crucial role in minimising weight regain after stopping treatment.

While semaglutide can lead to significant weight loss, most users experience partial regain after discontinuation. Combining the drug with healthy eating and exercise may help sustain some of the benefits. For those seeking long-term results, ongoing support from healthcare professionals remains important.